Recorded ISHLT Webinars


 

Around the World of Cardiogenic Shock: Interdisciplinary Research and Education

Wednesday, 25 August, 2021, 12:00 – 1:00 p.m. EDT

This webinar will highlight global perspectives from active working groups in cardiogenic shock with focused projections on the contributions (registry, consortiums, etc.) of each group/country through the ISHLT interdisciplinary framework.
 

 

VAD Implantation: Standard vs Alternative Approaches

Wednesday, 28 July, 2021, 3:00 – 4:00 p.m. EDT

Durable mechanical circulatory support improves outcome and quality of life of patients with advanced heart failure. The surgical implantation approach may positively impact the outcome. The optimal surgical approach (median sternotomy vs less invasive approach) remains controversial. This webinar provides in-depth knowledge of the possible advantages of each approach.
 

 

Interactive Live Case Discussion: ECMO Bridge to Lung Transplant: A Bridge Too Far?

Wednesday, 28 July, 2021, 4:30 – 5:30 p.m. EDT

This interactive webinar will discuss some of the key issues associated with the “urgent referral for consideration of lung transplant in the patient with pulmonary hypertension who, not known to the transplant program, has crashed onto ECMO”. Following discussion of the index case, brief overviews will be provided by international experts on topics related to compromised assessment pathways, medical therapy of end-stage pulmonary hypertension, ECLS options and post-transplant care in the intensive care unit.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.

 

 

Deep Dive into Oral Presentations from ISHLT2021

         
   
   

Wednesday, 16 June, 2021, 4:00 – 5:00 p.m. EDT

This webinar features four oral presentations based on top-scoring abstracts, covering a multidisciplinary range of topics spanning all four core therapies featured at the 2021 ISHLT Annual Meeting & Scientific Sessions. The 2021 and 2020 Scientific Program Chairs will conduct in-depth interviews with each presenter, and the program will conclude with a message from the 2022 Scientific Program Chair.
 
 

Interactive Live Case Discussion: Failing Fontan and Transplantation

Wednesday, 26 May, 2021, 12:00 – 1:00 p.m. EDT

This interactive webinar will provide some of the key problems associated with failing Fontan adult and pediatric patients both before and after transplantation with international experts. Along discussion of an exemplary case, brief overviews will be provided on the current knowledge on protein losing enteropathy, elevated pulmonary vascular pressures, ventricular assist device options and liver assessment and consideration of combined heart liver transplantation followed by open discussion of each point and panel discussion of any other arising questions towards the end of the session.
 
 

All Mod Cons: RHC Pearls and Gems in Pulmonary Hypertension

Wednesday, 26 May, 2021, 3:00 – 4:00 p.m. EDT

Right heart catheterization is the gold standard for the assessment of pulmonary hypertension. It is critical at different steps in the differential diagnosis and the distinction between post and pre capillary PH. It also provides insights on outcome and is an important guide for treatment decisions in pulmonary vascular diseases (PAH and CTEPH) and in advanced heart failure (MCS and HTX). Although widely used in clinical practice, RHC requires specific knowledge both in data collection and interpretation of results.

This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.
 
 

The Ongoing COVID-19 Pandemic: Rising to the Challenge

Wednesday, 24 March, 2021 3:00 – 4:00 p.m. EDT

This webinar will provide an update on the ongoing COVID-19 pandemic by focusing on both ends of spectrum from infection prevention to management of severe disease. Speakers will summarize relevant clinical trial data from COVID-19 vaccination trials and what it means for our patients; and also discuss basic pathophysiology of COVID-19 related acute respiratory distress syndrome and new insights in management via extra corporeal membrane oxygenation (ECMO).
 
 

Deep Dive on Hot Topics at JHLT

Wednesday, 27 January, 2021 3:00 – 4:00 p.m. EST

Join the new Editorial Team at the Journal of Heart and Lung Transplantation as they discuss three recent JHLT publications spanning experimental research in lung transplantation, pediatric transplantation, and adult heart transplantation.
 
 

Anticoagulation and Bleeding Complications in MCS Patients

Wednesday, 16 December, 2020 11:00 a.m. – 12:30 p.m. EST

Developed from ISHLT2020 SESSION 29 (ORAL)
 
 

Building on a Solid Foundation: Guidelines and Unique Challenges in CF Lung Transplant

Wednesday, 16 December, 2020 4:00 – 5:30 p.m. EST

Developed from ISHLT2020 SUNRISE 04

The focus of this session is to provide an in-depth assessment of CF specific considerations in lung transplant. Recently published referral guidelines will be reviewed with a focus on issues such as adherence and psychosocial factors. Identification of at-risk patients and strategies to enhance waitlist survival will be undertaken. CF specific pre transplant issues and how they influence candidacy will be reviewed including liver disease, non adherence, vascular anatomy and other GIT manifestations.
 
 

Update on COVID-19 and Challenges in Cardiothoracic Transplantation

Wednesday, 18 November, 2020 2:00 – 3:30 p.m. EST

The ongoing COVID-19 pandemic has had significant global impact on cardiothoracic transplantation. The ISHLT COVID-19 webinar will discuss various aspects of the pandemic on heart and lung transplantation using a case-based approach. Topics include infectivity of SAR-CoV-2, management of wait listed patients infected with or exposed to SARS-CoV-2, summary of recent COVID-19 therapeutic trials and implications for transplant recipients, and lung transplant evaluation and listing criteria for COVID-19 related respiratory failure.
 
 

Segmental and Subsegmental Disease in CTEPH: Misconception and Missed Opportunities

Wednesday, 28 October, 2020, 10:00 – 11:30 a.m. EDT

Developed from ISHLT2020 SESSION 34 (SYMPOSIUM)

This symposium will specifically focus on segmental and subsegmental disease in CTEPH. The management of segmental and subsegmental disease has evolved over the past decade. Pulmonary endarterectomy and balloon pulmonary angioplasty have been shown to be excellent therapeutic options for these patients. However, both options have not yet been widely adopted due to technical challenges.
 
 

Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk

Wednesday, 28 October, 2020 1:00 – 2:30 p.m. EDT

Developed from ISHLT2020 SESSION 72 (ORAL)
 
 

When a Single Ventricle Support is Not Enough

Wednesday, 30 September, 2020 8:00 – 9:30 a.m. EDT

Developed from ISHLT2020 SESSION 64 (SYMPOSIUM)

Biventricular failure is associated with high in-hospital mortality. The aim of this session is to explore the clinical utility of extra- and intracorporeal as well as percutaneous MCS for patients persisting biventricular failure. In this session the currently available devices for treating shock and heart failure and a look ahead within this developing field, including new devices and novel indications for established technology should be presented.
 
 

Molecular Mechanisms of Allograft Injury and CLAD

Wednesday, 30 September, 2020 4:00 – 5:30 p.m. EDT

Developed from ISHLT2020 SESSION 69 (ORAL)
 
 

Pulmonary Hypertension: Where We're Going We Don't Need Roads

Wednesday, 22 July, 2020 10:00 – 11:30 a.m. EDT

Developed from: ISHLT2020 SESSION 05 (ORAL)
 
 

The Evolving Science of Shock Recognition and Management

Wednesday, 22 July, 2020 4:00 – 5:30 p.m. EDT

Developed from: ISHLT2020 SESSION 02 (SYMPOSIUM)

This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.
 
 

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections II

Wednesday, 24 June, 2020 4:00 – 5:30 p.m. EDT

Features selected content from Plenary Sessions scheduled for presentation at the 2020 Anniversary Meeting and Scientific Sessions, including MAID - Medical Assistance in Dying: Implications for Transplantation by James Downar, MDCM, MHSc and three Featured Abstract Presentations
 
 

New Frontiers in Heart and Lung Transplantation: ISHLT2020 Plenary Session Selections I

Wednesday, 27 May, 2020

Features select presentations developed for presentation in Plenary Sessions at the 2020 Anniversary Meeting and Scientific Sessions, including Translating Tissue Engineered Heart Repair by Wolfram Zimmermann, MD, Management of Lung Failure in 2040: Artificial Lung or Regeneration? by Shaf Keshavjee, MD, MSc, FRCSC, FACS, and two Featured Abstract Presentations
 
 

COVID-19 and Challenges in Advanced Heart and Lung Disease and Cardiothoracic Transplantation

Wednesday, 29 April, 2020

The rapid spread of COVID-19, caused by the SARS-CoV-2 coronavirus, has affected all aspects of medical care, including advanced heart and lung disease and cardiothoracic transplantation. Clinical presentation, current epidemiology, therapeutic options, critical care, support devices and donor management will be included among the aspects of patient care explored in this session. Additionally, first-hand experiences from the frontlines of the pandemic will be presented.